Tlr5 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| TLR5 Gene |
|---|
| Gene Symbol | TLR5 |
| Full Name | Toll-Like Receptor 5 |
| Chromosomal Location | 1q41 |
| NCBI Gene ID | 7100 |
| OMIM | 603030 |
| Ensembl ID | ENSG00000135831 |
| UniProt | Q9R279 |
| Protein Class | Pattern Recognition Receptor (TLR family) |
| Associated Diseases | Alzheimer's Disease, Parkinson's Disease, Neuroinflammation, Autoimmune Disorders, Sepsis |
TLR5 (Toll-Like Receptor 5) encodes a pattern recognition receptor of the innate immune system that primarily recognizes bacterial flagellin—the protein component of bacterial flagella. Located on chromosome 1q41, TLR5 is a type I transmembrane protein expressed in various immune cells and tissues throughout the body. While traditionally studied in the context of bacterial infection recognition, recent research has revealed important roles for TLR5 in neuroinflammation and neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease. The receptor serves as a critical link between the gut microbiome and the brain, mediating the effects of bacterial products on neuroinflammation and neuronal survival.
TLR5 belongs to the Toll-like receptor family, which comprises 10 functional receptors (TLR1-TLR10) in humans. These receptors represent a first line of defense against pathogens by recognizing conserved molecular patterns called pathogen-associated molecular patterns (PAMPs). TLR5 is unique among TLRs in its highly specific recognition of flagellin, which distinguishes it from other pattern recognition receptors that recognize more diverse microbial components.
¶ Extracellular Domain
The TLR5 protein contains several structural features essential for its function:
- Leucine-rich repeat (LRR) domain: The extracellular portion consists of 23 LRR motifs that form a solenoid structure responsible for flagellin recognition
- LRRCT and LRRNT caps: Terminal capping motifs that stabilize the LRR fold
- Flagellin-binding pocket: A specific binding site that recognizes conserved regions of flagellin
- N-linked glycosylation sites: Post-translational modifications that affect protein folding and localization
¶ Transmembrane Domain
- Single-pass transmembrane helix: Spans the plasma membrane
- Sorting motif: Directs receptor trafficking to cellular membranes
¶ Intracellular Domain
- TIR domain (Toll/IL-1 receptor domain): The cytoplasmic signaling domain approximately 200 amino acids long
- BB loop: Critical for downstream signaling adaptor recruitment
- Death domain: Involved in apoptosis signaling in some contexts
TLR5's primary function is detection of bacterial flagellin:
- Flagellin recognition: Binds monomeric flagellin from gram-negative and some gram-positive bacteria
- Dimerization: TLR5 forms homodimers upon flagellin binding, initiating signaling
- MyD88 recruitment: The adaptor protein MyD88 is recruited to the TIR domain
- Downstream signaling: Activation of NF-κB and MAPK pathways
- Proinflammatory response: Production of cytokines, chemokines, and antimicrobial effectors
TLR5 activates several downstream signaling cascades:
| Pathway |
Key Components |
Outcome |
| MyD88-dependent |
MyD88 → IRAK4 → TRAF6 → TAK1 |
NF-κB and MAPK activation |
| NF-κB pathway |
IKK complex → IκB degradation |
Proinflammatory gene expression |
| MAPK pathway |
ERK, JNK, p38 activation |
Cytokine production, cell survival |
| IRF pathway |
IRF5, IRF8 activation |
Type I interferon response |
In immune cells, TLR5 signaling regulates:
- Macrophage activation: Enhanced phagocytosis and antimicrobial activity
- Dendritic cell maturation: Improved antigen presentation
- Neutrophil recruitment: Chemotaxis and inflammatory responses
- B cell activation: Antibody production enhancement
- Cytokine production: TNF-α, IL-1β, IL-6, IL-12, and others
TLR5 is highly expressed in various immune cells:
- Monocytes/macrophages: High expression, robust flagellin responses
- Dendritic cells: Moderate to high expression
- Neutrophils: High expression for rapid responses
- B cells: Low to moderate expression
- T cells: Limited expression, mainly upon activation
- Intestinal epithelium: Highest expression in gut (small intestine, colon)
- Respiratory epithelium: Lower expression in lung
- Liver: Kupffer cells express TLR5
- Skin: Epithelial cells, particularly in barrier tissues
Within the central nervous system, TLR5 expression has been characterized:
- Microglia: Primary CNS immune cells express TLR5 and respond to flagellin
- Astrocytes: Low basal expression, upregulated under inflammatory conditions
- Neurons: Limited expression, may increase in disease states
- Endothelial cells: Blood-brain barrier cells can express TLR5
The expression pattern suggests that TLR5 on microglia is the primary mediator of flagellin-induced neuroinflammation.
TLR5 serves as a critical receptor linking gut microbiota to brain function:
- Bacterial flagellin detection: Gut epithelial cells and immune cells detect flagellin from commensal and pathogenic bacteria
- Systemic inflammation: TLR5 activation leads to proinflammatory cytokine release
- Blood-brain barrier penetration: Flagellin and inflammatory mediators can cross or affect the blood-brain barrier
- Microglial activation: Brain microglia respond to circulating flagellin via TLR5
- Neuroinflammation: Chronic TLR5 activation contributes to neuroinflammation
This pathway provides a mechanistic link between gut dysbiosis and neurodegenerative diseases.
TLR5 has several connections to Alzheimer's disease pathogenesis:
- Microglial activation: TLR5 on microglia can be activated by bacterial flagellin, leading to chronic neuroinflammation
- Amyloid interaction: Some studies suggest TLRs can interact with amyloid-beta, potentially modulating its clearance
- Gut microbiome effects: Alterations in gut microbiota affect AD progression through TLR5
- Inflammatory milieu: Chronic low-level TLR5 activation creates a pro-inflammatory environment
- Neuronal vulnerability: TLR5-induced inflammation may exacerbate neuronal death
TLR5 plays a significant role in Parkinson's disease through:
- Gut microbiome-parkinsonism link: Studies show gut dysbiosis precedes PD motor symptoms
- Alpha-synuclein propagation: TLR5 activation may facilitate misfolded alpha-synuclein spread
- Microglial TLR5: Activated microglia produce proinflammatory cytokines that damage dopaminergic neurons
- Enteric nervous system: TLR5 in the gut may initiate the pathological process
- Animal models: TLR5 knockout mice show reduced neuroinflammation in PD models
Research by Sampson et al. demonstrated that gut microbiota regulate motor deficits and neuroinflammation in a mouse model of Parkinson's disease, with TLR5 playing a key mediating role.
TLR5 contributes to neuroinflammation through several mechanisms:
- Microglial activation: Flagellin binding triggers microglial morphological and functional changes
- Cytokine storm: Production of TNF-α, IL-1β, IL-6, and other proinflammatory mediators
- Nitric oxide production: Induces NOS expression, leading to neurotoxic NO
- Reactive oxygen species: NADPH oxidase activation and oxidative stress
- Matrix metalloproteinases: Degradation of blood-brain barrier components
- Neuronal dysfunction: Direct effects on neuronal viability
Modulating TLR5 signaling represents a potential therapeutic strategy:
| Approach |
Strategy |
Current Status |
| TLR5 antagonists |
Flagellin-derived peptides |
Preclinical |
| Anti-inflammatory agents |
Natural compounds (curcumin, resveratrol) |
Preclinical/clinical |
| Microbiome modulation |
Probiotics, prebiotics, diet |
Investigational |
| Flagellin blockade |
Monoclonal antibodies |
Research |
- Balance of immunity: Complete TLR5 inhibition may compromise host defense
- Dose-dependent effects: Low vs. high flagellin may have different effects
- Individual variability: Genetic variation in TLR5 affects responses
- Microbiome complexity: Multiple factors beyond TLR5 influence outcomes
Common variants in TLR5 affect function:
- R392X (stop codon): Loss-of-function variant affecting flagellin sensing
- F474L: Missense variant with altered signaling
- Promoter variants: Affect expression levels
These polymorphisms may influence susceptibility to infections and inflammatory diseases.
Current areas of active investigation include:
- Structural studies: Understanding flagellin-TLR5 interaction at atomic resolution
- Selective agonists/antagonists: Developing modulators with better specificity
- Biomarkers: Identifying TLR5-related biomarkers for neurodegenerative diseases
- Clinical trials: Testing microbiome-based interventions
- Animal models: Further characterizing TLR5's role in neurodegeneration
- Hayashi et al., The innate immune response to bacterial flagellin (2001) — Original characterization of TLR5 as flagellin receptor
- Sampson et al., Gut microbiota regulate motor deficits and neuroinflammation in PD (2016) — Key study linking gut microbiome to Parkinson's disease
- Vijay et al., TLR5 in neuroinflammation and neurodegeneration (2018) — Role of TLR5 in CNS diseases
- Chen et al., Gut microbiome and Alzheimer's disease (2019) — Microbiome-TLR5-AD connection
- Letiembre et al., TLRs in Alzheimer's disease brain (2005) — TLR expression in AD
The study of Tlr5 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Hayashi et al., The innate immune response to bacterial flagellin (2001)
- Sampson et al., Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson's disease (2016)
- Vijay et al., TLR5 in neuroinflammation and neurodegeneration (2018)
- Chen et al., Gut microbiome and Alzheimer's disease (2019)
- Letiembre et al., TLRs in Alzheimer's disease brain (2005)
- Kawai and Akira, TLR signaling (2007)
- Glass et al., Microglial identity and inflammatory responses in Alzheimer's disease (2010)
- Heneka et al., Neuroinflammation in Alzheimer's disease (2015)